APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vinorelbine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vinorelbine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchVinorelbine Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Vinorelbine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Vinorelbine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vinorelbine Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Vinorelbine Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Vinorelbine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Vinorelbine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vinorelbine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vinorelbine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vinorelbine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vinorelbine include TEVA Pharms, Shenzhen Main Luck Pharmaceuticals Inc., Shanxi Powerdone Pharmaceutics Co., Ltd., Qilu Pharmaceutical (Hainan) Co., Ltd., Mylan, Luoxin Pharmaceutical Group Co., Ltd., Hangzhou Minsheng Pharmaceutical Group Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vinorelbine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vinorelbine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vinorelbine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vinorelbine market size, projected growth trends, production technologies, key applications, and end-use industries.

Vinorelbine Segment by Company

TEVA Pharms

Shenzhen Main Luck Pharmaceuticals Inc.

Shanxi Powerdone Pharmaceutics Co., Ltd.

Qilu Pharmaceutical (Hainan) Co., Ltd.

Mylan

Luoxin Pharmaceutical Group Co., Ltd.

Hangzhou Minsheng Pharmaceutical Group Co., Ltd.

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Fresenius Kabi

Nanjing Cuccess Pharmaceutical Co., Ltd

Beijing SL Pharm

West-Ward Pharmaceuticals Corp.

Sinopharm A-Think Pharmaceutical Co., Ltd.

Pierre Fabre Pharmaceuticals, Inc.

Hospira, Inc.

EBEWE Pharma (Sandoz A Novartis Division)

Dr. Reddy's Laboratories

Vinorelbine Segment by Type

Oral

Injection

Vinorelbine Segment by Application

Breast Cancer

Non-small Cell Lung Cancer

Other

Vinorelbine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinorelbine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vinorelbine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinorelbine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vinorelbine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vinorelbine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vinorelbine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vinorelbine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vinorelbine Industry Trends Table 2. Vinorelbine Industry Drivers Table 3. Vinorelbine Industry Opportunities and Challenges Table 4. Vinorelbine Industry Restraints Table 5. Global Vinorelbine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vinorelbine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vinorelbine Sales by Manufacturers (tons) & (2021-2026) Table 8. Global Vinorelbine Sales Market Share by Manufacturers Table 9. Global Vinorelbine Average Sales Price (US$/kg) of Manufacturers (2021-2026) Table 10. Global Vinorelbine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vinorelbine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vinorelbine Manufacturers, Product Type & Application Table 13. Global Vinorelbine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vinorelbine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global Vinorelbine Sales by Type 2021 VS 2025 VS 2032 (tons) Table 19. Global Vinorelbine Sales by Type (2021-2026) & (tons) Table 20. Global Vinorelbine Sales by Type (2027-2032) & (tons) Table 21. Global Vinorelbine Sales Market Share by Type (2021-2026) Table 22. Global Vinorelbine Sales Market Share by Type (2027-2032) Table 23. Global Vinorelbine Revenue by Type 2021 VS 2025 VS 2032 (tons) Table 24. Global Vinorelbine Revenue by Type (2021-2026) & (tons) Table 25. Global Vinorelbine Revenue by Type (2027-2032) & (tons) Table 26. Global Vinorelbine Revenue Market Share by Type (2021-2026) Table 27. Global Vinorelbine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Breast Cancer Table 29. Major Manufacturers of Non-small Cell Lung Cancer Table 30. Major Manufacturers of Other Table 31. Global Vinorelbine Sales by Application 2021 VS 2025 VS 2032 (tons) Table 32. Global Vinorelbine Sales by Application (2021-2026) & (tons) Table 33. Global Vinorelbine Sales by Application (2027-2032) & (tons) Table 34. Global Vinorelbine Sales Market Share by Application (2021-2026) Table 35. Global Vinorelbine Sales Market Share by Application (2027-2032) Table 36. Global Vinorelbine Revenue by Application 2021 VS 2025 VS 2032 (tons) Table 37. Global Vinorelbine Revenue by Application (2021-2026) & (tons) Table 38. Global Vinorelbine Revenue by Application (2027-2032) & (tons) Table 39. Global Vinorelbine Revenue Market Share by Application (2021-2026) Table 40. Global Vinorelbine Revenue Market Share by Application (2027-2032) Table 41. Global Vinorelbine Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 42. Global Vinorelbine Sales by Region (2021-2026) & (tons) Table 43. Global Vinorelbine Sales Market Share by Region (2021-2026) Table 44. Global Vinorelbine Sales Forecasted by Region (2027-2032) & (tons) Table 45. Global Vinorelbine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 47. North America Vinorelbine Sales by Country (2021-2026) & (tons) Table 48. North America Vinorelbine Sales by Country (2027-2032) & (tons) Table 49. Europe Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 50. Europe Vinorelbine Sales by Country (2021-2026) & (tons) Table 51. Europe Vinorelbine Sales by Country (2027-2032) & (tons) Table 52. Asia Pacific Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 53. Asia Pacific Vinorelbine Sales by Country (2021-2026) & (tons) Table 54. Asia Pacific Vinorelbine Sales by Country (2027-2032) & (tons) Table 55. South America, Middle East and Africa Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 56. South America, Middle East and Africa Vinorelbine Sales by Country (2021-2026) & (tons) Table 57. South America, Middle East and Africa Vinorelbine Sales by Country (2027-2032) & (tons) Table 58. Global Vinorelbine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Vinorelbine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Vinorelbine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Vinorelbine Revenue Market Share by Region (2021-2026) Table 62. Global Vinorelbine Revenue Market Share by Region (2027-2032) Table 63. TEVA Pharms Company Information Table 64. TEVA Pharms Business Overview Table 65. TEVA Pharms Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. TEVA Pharms Vinorelbine Product Portfolio Table 67. TEVA Pharms Recent Development Table 68. Shenzhen Main Luck Pharmaceuticals Inc. Company Information Table 69. Shenzhen Main Luck Pharmaceuticals Inc. Business Overview Table 70. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product Portfolio Table 72. Shenzhen Main Luck Pharmaceuticals Inc. Recent Development Table 73. Shanxi Powerdone Pharmaceutics Co., Ltd. Company Information Table 74. Shanxi Powerdone Pharmaceutics Co., Ltd. Business Overview Table 75. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product Portfolio Table 77. Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Development Table 78. Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information Table 79. Qilu Pharmaceutical (Hainan) Co., Ltd. Business Overview Table 80. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product Portfolio Table 82. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Mylan Vinorelbine Product Portfolio Table 87. Mylan Recent Development Table 88. Luoxin Pharmaceutical Group Co., Ltd. Company Information Table 89. Luoxin Pharmaceutical Group Co., Ltd. Business Overview Table 90. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product Portfolio Table 92. Luoxin Pharmaceutical Group Co., Ltd. Recent Development Table 93. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Company Information Table 94. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Business Overview Table 95. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product Portfolio Table 97. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Recent Development Table 98. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information Table 99. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Business Overview Table 100. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product Portfolio Table 102. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Development Table 103. Fresenius Kabi Company Information Table 104. Fresenius Kabi Business Overview Table 105. Fresenius Kabi Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Fresenius Kabi Vinorelbine Product Portfolio Table 107. Fresenius Kabi Recent Development Table 108. Nanjing Cuccess Pharmaceutical Co., Ltd Company Information Table 109. Nanjing Cuccess Pharmaceutical Co., Ltd Business Overview Table 110. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product Portfolio Table 112. Nanjing Cuccess Pharmaceutical Co., Ltd Recent Development Table 113. Beijing SL Pharm Company Information Table 114. Beijing SL Pharm Business Overview Table 115. Beijing SL Pharm Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Beijing SL Pharm Vinorelbine Product Portfolio Table 117. Beijing SL Pharm Recent Development Table 118. West-Ward Pharmaceuticals Corp. Company Information Table 119. West-Ward Pharmaceuticals Corp. Business Overview Table 120. West-Ward Pharmaceuticals Corp. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. West-Ward Pharmaceuticals Corp. Vinorelbine Product Portfolio Table 122. West-Ward Pharmaceuticals Corp. Recent Development Table 123. Sinopharm A-Think Pharmaceutical Co., Ltd. Company Information Table 124. Sinopharm A-Think Pharmaceutical Co., Ltd. Business Overview Table 125. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product Portfolio Table 127. Sinopharm A-Think Pharmaceutical Co., Ltd. Recent Development Table 128. Pierre Fabre Pharmaceuticals, Inc. Company Information Table 129. Pierre Fabre Pharmaceuticals, Inc. Business Overview Table 130. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product Portfolio Table 132. Pierre Fabre Pharmaceuticals, Inc. Recent Development Table 133. Hospira, Inc. Company Information Table 134. Hospira, Inc. Business Overview Table 135. Hospira, Inc. Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Hospira, Inc. Vinorelbine Product Portfolio Table 137. Hospira, Inc. Recent Development Table 138. EBEWE Pharma (Sandoz A Novartis Division) Company Information Table 139. EBEWE Pharma (Sandoz A Novartis Division) Business Overview Table 140. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product Portfolio Table 142. EBEWE Pharma (Sandoz A Novartis Division) Recent Development Table 143. Dr. Reddy's Laboratories Company Information Table 144. Dr. Reddy's Laboratories Business Overview Table 145. Dr. Reddy's Laboratories Vinorelbine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Dr. Reddy's Laboratories Vinorelbine Product Portfolio Table 147. Dr. Reddy's Laboratories Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Vinorelbine Distributors List Table 151. Vinorelbine Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Vinorelbine Product Image Figure 2. Global Vinorelbine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vinorelbine Market Size (2021-2032) & (US$ Million) Figure 4. Global Vinorelbine Sales (2021-2032) & (tons) Figure 5. Global Vinorelbine Average Price (US$/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Vinorelbine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global Vinorelbine Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 11. Global Vinorelbine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Vinorelbine Sales Market Share by Type (2021-2032) Figure 13. Global Vinorelbine Revenue by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Vinorelbine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Vinorelbine Revenue Market Share by Type (2021-2032) Figure 16. Breast Cancer Image Figure 17. Non-small Cell Lung Cancer Image Figure 18. Other Image Figure 19. Global Vinorelbine Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 20. Global Vinorelbine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Vinorelbine Sales Market Share by Application (2021-2032) Figure 22. Global Vinorelbine Revenue by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Vinorelbine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Vinorelbine Revenue Market Share by Application (2021-2032) Figure 25. North America Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 26. North America Vinorelbine Sales Market Share by Country (2021-2032) Figure 27. U.S. Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 28. Canada Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 29. Mexico Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 30. Europe Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 31. Europe Vinorelbine Sales Market Share by Country (2021-2032) Figure 32. Germany Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 33. France Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 34. U.K. Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 35. Italy Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 36. Netherlands Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 37. Asia Pacific Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 38. Asia Pacific Vinorelbine Sales Market Share by Country (2021-2032) Figure 39. China Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 40. Japan Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 41. South Korea Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 42. Southeast Asia Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 43. India Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 44. Australia Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 45. South America, Middle East and Africa Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 46. South America, Middle East and Africa Vinorelbine Sales Market Share by Country (2021-2032) Figure 47. Brazil Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 48. South Africa Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 49. Saudi Arabia Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 50. Turkey Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 51. Argentina Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 52. UAE Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 53. Egypt Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 54. Chile Vinorelbine Sales and Growth Rate (2021-2032) & (tons) Figure 55. Global Vinorelbine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Vinorelbine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Vinorelbine Revenue (2021-2032) & (US$ Million) Figure 58. North America Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Vinorelbine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Vinorelbine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Vinorelbine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Vinorelbine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Vinorelbine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Breast Cancer
  • Non-small Cell Lung Cancer
  • Other
Companies covered
  • TEVA Pharms
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • Shanxi Powerdone Pharmaceutics Co., Ltd.
  • Qilu Pharmaceutical (Hainan) Co., Ltd.
  • Mylan
  • Luoxin Pharmaceutical Group Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  • Fresenius Kabi
  • Nanjing Cuccess Pharmaceutical Co., Ltd
  • Beijing SL Pharm
  • West-Ward Pharmaceuticals Corp.
  • Sinopharm A-Think Pharmaceutical Co., Ltd.
  • Pierre Fabre Pharmaceuticals, Inc.
  • Hospira, Inc.
  • EBEWE Pharma (Sandoz A Novartis Division)
  • Dr. Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vinorelbine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vinorelbine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vinorelbine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vinorelbine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vinorelbine Market Dynamics
  1. 2.1 Vinorelbine Industry Trends
  2. 2.2 Vinorelbine Industry Drivers
  3. 2.3 Vinorelbine Industry Opportunities and Challenges
  4. 2.4 Vinorelbine Industry Restraints
3 Vinorelbine Market by Manufacturers
  1. 3.1 Global Vinorelbine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vinorelbine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vinorelbine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vinorelbine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vinorelbine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vinorelbine Manufacturers, Product Type & Application
  7. 3.7 Global Vinorelbine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vinorelbine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vinorelbine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vinorelbine Tier 1, Tier 2, and Tier 3
4 Vinorelbine Market by Type
  1. 4.1 Vinorelbine Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Vinorelbine Sales by Type
  5. 4.2.1 Global Vinorelbine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vinorelbine Sales by Type (2021-2032)
  7. 4.2.3 Global Vinorelbine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Vinorelbine Revenue by Type
  9. 4.3.1 Global Vinorelbine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Vinorelbine Revenue by Type (2021-2032)
  11. 4.3.3 Global Vinorelbine Revenue Market Share by Type (2021-2032)
5 Vinorelbine Market by Application
  1. 5.1 Vinorelbine Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Non-small Cell Lung Cancer
  4. 5.1.3 Other
  5. 5.2 Global Vinorelbine Sales by Application
  6. 5.2.1 Global Vinorelbine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vinorelbine Sales by Application (2021-2032)
  8. 5.2.3 Global Vinorelbine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Vinorelbine Revenue by Application
  10. 5.3.1 Global Vinorelbine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vinorelbine Revenue by Application (2021-2032)
  12. 5.3.3 Global Vinorelbine Revenue Market Share by Application (2021-2032)
6 Global Vinorelbine Sales by Region
  1. 6.1 Global Vinorelbine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vinorelbine Sales by Region (2021-2032)
  3. 6.2.1 Global Vinorelbine Sales by Region (2021-2026)
  4. 6.2.2 Global Vinorelbine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vinorelbine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vinorelbine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vinorelbine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vinorelbine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vinorelbine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vinorelbine Revenue by Region
  1. 7.1 Global Vinorelbine Revenue by Region
  2. 7.1.1 Global Vinorelbine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vinorelbine Revenue by Region (2021-2026)
  4. 7.1.3 Global Vinorelbine Revenue by Region (2027-2032)
  5. 7.1.4 Global Vinorelbine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vinorelbine Revenue (2021-2032)
  8. 7.2.2 North America Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vinorelbine Revenue (2021-2032)
  11. 7.3.2 Europe Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vinorelbine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vinorelbine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vinorelbine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 TEVA Pharms
  2. 8.1.1 TEVA Pharms Company Information
  3. 8.1.2 TEVA Pharms Business Overview
  4. 8.1.3 TEVA Pharms Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 TEVA Pharms Vinorelbine Product Portfolio
  6. 8.1.5 TEVA Pharms Recent Developments
  7. 8.2 Shenzhen Main Luck Pharmaceuticals Inc.
  8. 8.2.1 Shenzhen Main Luck Pharmaceuticals Inc. Company Information
  9. 8.2.2 Shenzhen Main Luck Pharmaceuticals Inc. Business Overview
  10. 8.2.3 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product Portfolio
  12. 8.2.5 Shenzhen Main Luck Pharmaceuticals Inc. Recent Developments
  13. 8.3 Shanxi Powerdone Pharmaceutics Co., Ltd.
  14. 8.3.1 Shanxi Powerdone Pharmaceutics Co., Ltd. Company Information
  15. 8.3.2 Shanxi Powerdone Pharmaceutics Co., Ltd. Business Overview
  16. 8.3.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product Portfolio
  18. 8.3.5 Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Developments
  19. 8.4 Qilu Pharmaceutical (Hainan) Co., Ltd.
  20. 8.4.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information
  21. 8.4.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Business Overview
  22. 8.4.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product Portfolio
  24. 8.4.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Vinorelbine Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Luoxin Pharmaceutical Group Co., Ltd.
  32. 8.6.1 Luoxin Pharmaceutical Group Co., Ltd. Company Information
  33. 8.6.2 Luoxin Pharmaceutical Group Co., Ltd. Business Overview
  34. 8.6.3 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product Portfolio
  36. 8.6.5 Luoxin Pharmaceutical Group Co., Ltd. Recent Developments
  37. 8.7 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
  38. 8.7.1 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Company Information
  39. 8.7.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Business Overview
  40. 8.7.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product Portfolio
  42. 8.7.5 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Recent Developments
  43. 8.8 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  44. 8.8.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
  45. 8.8.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Business Overview
  46. 8.8.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product Portfolio
  48. 8.8.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments
  49. 8.9 Fresenius Kabi
  50. 8.9.1 Fresenius Kabi Company Information
  51. 8.9.2 Fresenius Kabi Business Overview
  52. 8.9.3 Fresenius Kabi Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fresenius Kabi Vinorelbine Product Portfolio
  54. 8.9.5 Fresenius Kabi Recent Developments
  55. 8.10 Nanjing Cuccess Pharmaceutical Co., Ltd
  56. 8.10.1 Nanjing Cuccess Pharmaceutical Co., Ltd Company Information
  57. 8.10.2 Nanjing Cuccess Pharmaceutical Co., Ltd Business Overview
  58. 8.10.3 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product Portfolio
  60. 8.10.5 Nanjing Cuccess Pharmaceutical Co., Ltd Recent Developments
  61. 8.11 Beijing SL Pharm
  62. 8.11.1 Beijing SL Pharm Company Information
  63. 8.11.2 Beijing SL Pharm Business Overview
  64. 8.11.3 Beijing SL Pharm Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Beijing SL Pharm Vinorelbine Product Portfolio
  66. 8.11.5 Beijing SL Pharm Recent Developments
  67. 8.12 West-Ward Pharmaceuticals Corp.
  68. 8.12.1 West-Ward Pharmaceuticals Corp. Company Information
  69. 8.12.2 West-Ward Pharmaceuticals Corp. Business Overview
  70. 8.12.3 West-Ward Pharmaceuticals Corp. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 West-Ward Pharmaceuticals Corp. Vinorelbine Product Portfolio
  72. 8.12.5 West-Ward Pharmaceuticals Corp. Recent Developments
  73. 8.13 Sinopharm A-Think Pharmaceutical Co., Ltd.
  74. 8.13.1 Sinopharm A-Think Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Sinopharm A-Think Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product Portfolio
  78. 8.13.5 Sinopharm A-Think Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Pierre Fabre Pharmaceuticals, Inc.
  80. 8.14.1 Pierre Fabre Pharmaceuticals, Inc. Company Information
  81. 8.14.2 Pierre Fabre Pharmaceuticals, Inc. Business Overview
  82. 8.14.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product Portfolio
  84. 8.14.5 Pierre Fabre Pharmaceuticals, Inc. Recent Developments
  85. 8.15 Hospira, Inc.
  86. 8.15.1 Hospira, Inc. Company Information
  87. 8.15.2 Hospira, Inc. Business Overview
  88. 8.15.3 Hospira, Inc. Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hospira, Inc. Vinorelbine Product Portfolio
  90. 8.15.5 Hospira, Inc. Recent Developments
  91. 8.16 EBEWE Pharma (Sandoz A Novartis Division)
  92. 8.16.1 EBEWE Pharma (Sandoz A Novartis Division) Company Information
  93. 8.16.2 EBEWE Pharma (Sandoz A Novartis Division) Business Overview
  94. 8.16.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product Portfolio
  96. 8.16.5 EBEWE Pharma (Sandoz A Novartis Division) Recent Developments
  97. 8.17 Dr. Reddy's Laboratories
  98. 8.17.1 Dr. Reddy's Laboratories Company Information
  99. 8.17.2 Dr. Reddy's Laboratories Business Overview
  100. 8.17.3 Dr. Reddy's Laboratories Vinorelbine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dr. Reddy's Laboratories Vinorelbine Product Portfolio
  102. 8.17.5 Dr. Reddy's Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vinorelbine Value Chain Analysis
  2. 9.1.1 Vinorelbine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vinorelbine Production Mode & Process
  6. 9.2 Vinorelbine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vinorelbine Distributors
  9. 9.2.3 Vinorelbine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst